doc. Mgr. Kamil Paruch, Ph.D.
Associate professor, Department of Chemistry
Correspondence Address:
Kotlářská 267/2, 611 37 Brno
Office: bldg. A08/322
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 5477 |
---|---|
E‑mail: |
Total number of publications: 148
2022
-
白血病、リンパ腫および固形腫瘍の治療に使用するための4-(1H-イミダゾール-5-イル)-1H-ピロロ[2,3-b]ピリジン
Publisher: Japan Patent Office, state: Japan, patent's number: JP7008967, year: 2022
2021
-
4—(1h— imidazol— 5— yl) -1h-pyrrolo (2, 3-b) pyridines for use in the treatment of leukaemias, lymphomas and solid tumors
Publisher: The Australian Patents Register, state: Australia, patent's number: AU 2019246220, year: 2021
-
Cytoprotective activities of kinetin purine isosteres
Bioorganic and Medicinal Chemistry, year: 2021, volume: 33, edition: March, DOI
-
Highly selective inhibitors of protein kinases CLK and HIPK with the furo[3,2-b]pyridine core
European Journal of Medicinal Chemistry, year: 2021, volume: 215, edition: April, DOI
-
CHK1 INHIBITOR SCH900776 ENHANCES ANTICANCER ACTION OF CISPLATIN AND TRAIL VIA STIMULATION OF BAK-DEPENDENT MITOCHONDRIAL PATHWAY
Year: 2021, type: Conference abstract
-
SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES
Publisher: European Patent Office, state: Germany, patent's number: EP3556755B1, year: 2021
2020
-
Cdc-Like Kinases (CLKs): Biology, Chemical Probes, and Therapeutic Potential
International Journal of Molecular Sciences, year: 2020, volume: 21, edition: 20, DOI
-
Furopyridines as inhibitors of protein kinases
Publisher: European Patent Office, state: Germany, patent's number: EP2940022, year: 2020
-
Substituted propanamides as inhibitors of nucleases
Publisher: European Patent Office, state: Germany, patent's number: EP3556756, year: 2020
-
The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe
Molecular oncology, year: 2020, volume: 14, edition: 10, DOI